Management of gastric cancer in Asia: resource-stratified guidelines

Lancet Oncol. 2013 Nov;14(12):e535-47. doi: 10.1016/S1470-2045(13)70436-4.

Abstract

Gastric cancer is the fourth most common cancer globally, and is the second most common cause of death from cancer worldwide. About three-quarters of newly diagnosed cases in 2008 were from Asian countries. With a high mortality-to-incidence ratio, management of gastric cancer is challenging. We discuss evidence for optimum management of gastric cancer in aspects of screening and early detection, diagnosis, and staging; endoscopic and surgical intervention; and the concepts of perioperative, postoperative, and palliative chemotherapy and use of molecularly targeted therapy. Recommendations are formulated on the basis of the framework provided by the Breast Health Global Initiative, using the categories of basic, limited, enhanced, and maximum level. We aim to provide a stepwise strategy for management of gastric cancer applicable to different levels of health-care resources in Asian countries.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Asia / epidemiology
  • Chemotherapy, Adjuvant / standards
  • Delivery of Health Care / standards
  • Early Detection of Cancer
  • Gastrectomy / standards
  • Gastroscopy / standards
  • Health Resources / economics
  • Health Resources / standards*
  • Health Services Accessibility / standards
  • Healthcare Disparities / standards
  • Humans
  • Medical Oncology / economics
  • Medical Oncology / standards*
  • Molecular Targeted Therapy / standards
  • Predictive Value of Tests
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents